Is 11β-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions?

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 17, 2004, Pages 6329-6330

  Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID;

ADDISON DISEASE; CUSHING SYNDROME; DRUG TARGETING; ENZYME ACTIVITY; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NOTE; PRIORITY JOURNAL; DRUG ANTAGONISM; METABOLISM; PATHOPHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADDISON DISEASE; CUSHING SYNDROME; GLUCOCORTICOIDS; HUMANS;

EID: 2342458276     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0401671101     Document Type: Note

References (17)

1. Chrousos, G. P. (2001) Endocrinology and Metabolism, eds. Felig, P. & Frohman, L., (McGraw-Hill, New York), 4th Ed., pp. 609-632.
2. Sandeep, T. C., Yau, J. L. W., MacLullich, A. M. J., Noble, J., Deary, I. J., Walker, B. R. & Seckl, J. R. (2004) Proc. Natl. Acad. Sci. USA 101, 6734-6739.
3. Franchimont, D., Kino, T., Galon, J., Meduri, G. U. & Chrousos, G. P. (2003) Neuronimmunomodulation 10, 247-260.
4. Chrousos, G. P., Charmandari, E. & Kino, T. (2004) J. Clin. Endocrinol. Metab. 89, 563-564.
5. Kino, T., De Martino, M. U., Charmandari, E., Mirani, M. & Chrousos, G. P. (2003) J. Steriod Biochem. Mol. Biol. 85, 457-467.
6. Chrousos, G. P. (1998) Ann. N. Y. Acad. Sci. 851, 311-335.
7. Miller, W. & Chrousos, G. P. (2001) Endocrinology and Metabolism, eds. Felig, P. & Frohman, L. (McGraw-Hill, New York), 4th Ed., pp. 387-524.
8. Dorn, L. D., Burgess, E. S., Dubbert, B., Kling, M., Gold, P. W. & Chrousos, G. P. (1995) Clin. Endocrinol. (Oxford) 43, 433-442.
9. Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W. & Chrousos, G. P. (1997) J. Clin. Endocrinol. Metab. 82, 912-919.
10. Hochberg, Z., Pacak, K. & Chrousos, G. P. (2003) Endocrine Rev. 24, 523-548.
11. Chrousos, G. P., Detera-Wadleigh, S. & Karl, M. (1993) Ann. Int. Med. 119, 1113-1124.
12. Laue, L., Lotze, M. T., Chrousos, G. P., Barnes, K., Loriaux, D. L. & Fleisher, T. A. (1990) J. Clin. Endocrinol. Metab. 71, 1474-1480.
13. Jamieson, A., Wallace, A. M., Andrew, R., Nunez, B. S., Walker, B. R., Fraser, R., White, P. C. & Connell, J. M. (1999) J. Clin. Endocrinol. Metab. 84, 3570-3574.
14. Pavlov, E. P., Harman, M. S., Chrousos, G. P., Loriaux, D. L. & Blackman, M. R. (1986) J. Clin. Endocrinol. Metab. 62, 767-772.
15. Vgontzas, A. N., Zoumakis, M., Bixler, E. O., Lin, H.-M., Prolo, P., Vela-Bueno, A., Kales, A. & Chrousos, G. P. (2003) J. Clin. Endocrinol. Metab. 88, 2087-2095.
16. Gold, P. W. & Chrousos, G. P. (2002) Mol. Psychiatry 7, 254-275.
17. Roy, M. S., Roy, A., Gallucci, W. T., Collier, B., Young, K., Kamilaris, T. C. & Chrousos, G. P. (1993) Metabolism 42, 696-700.